PMID- 25297945 OWN - NLM STAT- MEDLINE DCOM- 20150825 LR - 20141208 IS - 1399-0012 (Electronic) IS - 0902-0063 (Linking) VI - 28 IP - 12 DP - 2014 Dec TI - A single-center experience with 200 dual kidney transplantations. PG - 1433-40 LID - 10.1111/ctr.12475 [doi] AB - This study reports on a large series of 200 dual kidney transplantations (DKTs) from expanded criteria donors (ECDs) and proposes specific ways to optimize outcomes. Data concerning 200 DKTs performed in the last 14 yr were retrospectively analyzed. Kidneys from high-risk ECD were allocated for use in DKTs on an old-for-old basis after histological assessment. Different surgical techniques and immunosuppressant regimens were used over time, and the outcomes are discussed. Donors and recipients were a median 73 (70-77) and a 62 (58-67) yr old, respectively. Delayed graft function occurred in 31.5% of cases, and acute rejection in 13.5%. Patient and graft survival at five yr were 90.4% and 85.8%, respectively. Unilateral kidney placement was preferred for 75% of patients, and was associated with a low rate of surgical complications. Our current standard therapy comprising low-dose calcineurin inhibitors (CNIs) associated with mammalian target of rapamycin inhibitors (mTOR) and steroids appears to offer the best risk/benefit profile for elderly patients undergoing DKT. In our experience, outcomes after DKT can be improved by: (i) kidney clinical-histological assessment; (ii) unilateral kidney placement; (iii) minimal use of CNI associated with mTOR. CI - (c) 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. FAU - Rigotti, Paolo AU - Rigotti P AD - Kidney and Pancreas Transplantation Unit, Department of Surgical, Oncological and Gastroenterological Sciences, Padua University Hospital, University of Padua, Padua, Italy. FAU - Capovilla, Giovanni AU - Capovilla G FAU - Di Bella, Caterina AU - Di Bella C FAU - Silvestre, Cristina AU - Silvestre C FAU - Donato, Paola AU - Donato P FAU - Baldan, Nicola AU - Baldan N FAU - Furian, Lucrezia AU - Furian L LA - eng PT - Clinical Trial PT - Journal Article DEP - 20141104 PL - Denmark TA - Clin Transplant JT - Clinical transplantation JID - 8710240 RN - 0 (Immunosuppressive Agents) SB - IM MH - Aged MH - Female MH - Follow-Up Studies MH - Glomerular Filtration Rate MH - Graft Survival MH - Humans MH - Immunosuppressive Agents/*therapeutic use MH - Kidney Failure, Chronic/*surgery MH - Kidney Function Tests MH - Kidney Transplantation/*methods/mortality MH - Male MH - Middle Aged MH - *Postoperative Complications MH - Prognosis MH - Retrospective Studies MH - Risk Factors MH - Survival Rate MH - Tissue Donors/*statistics & numerical data MH - Tissue and Organ Harvesting/*methods OTO - NOTNLM OT - donor selection OT - dual kidney transplantation OT - immunosuppressant therapy OT - surgical technique EDAT- 2014/10/10 06:00 MHDA- 2015/08/26 06:00 CRDT- 2014/10/10 06:00 PHST- 2014/10/03 00:00 [accepted] PHST- 2014/10/10 06:00 [entrez] PHST- 2014/10/10 06:00 [pubmed] PHST- 2015/08/26 06:00 [medline] AID - 10.1111/ctr.12475 [doi] PST - ppublish SO - Clin Transplant. 2014 Dec;28(12):1433-40. doi: 10.1111/ctr.12475. Epub 2014 Nov 4.